Archives

img-01

Malaysia Drug Market Update 2017

Introduction In 2016, Malaysia’s economy expanded 5% and the population was at 30 million. The country also has the third highest GDP per capita adjusted for purchasing power pairty (PPP) in ASEAN at $27,000, behind only Singapore and Brunei (International Monetary Fund,... Read More

img-01

Thailand Drug Market Update 2017

Thailand, with a population of 68 million, is Southeast Asia’s third most populous country after Indonesia (256 million) and the Philippines (104 million). As the country continues to undergo economic growth and demographic changes, Thailand’s pharmaceutical market presents numerous opportunities for foreign... Read More

img-01

Asia’s Middle Class

Asia’s healthcare landscape is changing with its growing middle class. China, India and ASEAN’s middle classes are expected to grow by around 100 million people in the next ten years. Asia’s demand for healthcare will continue to grow with more people able... Read More

img-01

Diabetes In Asia

Studies have shown that Asians are at a higher risk of developing type II diabetes than Europeans. As Asia is continuing to develop, lifestyle diseases such as diabetes, hypertension, and high cholesterol are on the rise. About 70% of diabetes patients live... Read More